Back
CytoMed Therapeutics Stock Price Chart
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Buy
75
GDTC
CytoMed Therapeutics
Last Price:
2.49
Seasonality Move:
3.7%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GDTC is experiencing slight buying pressure.
CytoMed Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.47 | Buy |
| 20-day SMA: | 2.35 | Buy |
| 50-day SMA: | 1.88 | Buy |
| 200-day SMA: | 2.11 | Buy |
| 8-day EMA: | 2.47 | Buy |
| 20-day EMA: | 2.33 | Buy |
| 50-day EMA: | 2.07 | Buy |
| 200-day EMA: | 2.22 | Buy |
CytoMed Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 60.98 | Buy |
| Chaikin Money Flow: | 820 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.91 - 2.59) | Buy |
| Bollinger Bands (100): | (1.55 - 2.23) | Buy |
CytoMed Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CytoMed Therapeutics Stock
Is CytoMed Therapeutics Stock a Buy?
- CytoMed Therapeutics share price is 2.62 while GDTC 8-day simple moving average is 2.47, which is a Buy signal.
- The stock price of GDTC is 2.62 while CytoMed Therapeutics 20-day SMA is 2.35, which makes it a Buy.
- CytoMed Therapeutics 50-day simple moving average is 1.88 while GDTC share price is 2.62, making it a Buy technically.
- GDTC stock price is 2.62 and CytoMed Therapeutics 200-day simple moving average is 2.11, creating a Buy signal.
GDTC Technical Analysis vs Fundamental Analysis
Buy
75
CytoMed Therapeutics (GDTC)
is a Buy
Is CytoMed Therapeutics a Buy or a Sell?
-
CytoMed Therapeutics stock is rated a Buy
The current CytoMed Therapeutics [GDTC] share price is $2.62. The Score for GDTC is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
CytoMed Therapeutics Stock Info
Market Cap:
30.27M
Price in USD:
2.62
Share Volume:
53.82K
CytoMed Therapeutics 52-Week Range
52-Week High:
5.50
52-Week Low:
1.20
Buy
75
CytoMed Therapeutics (GDTC)
is a Buy
CytoMed Therapeutics Share Price Forecast
-
What is the CytoMed Therapeutics stock price today?
The CytoMed Therapeutics stock price is 2.62 USD today. -
Will GDTC stock go up or go down?
CytoMed Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is CytoMed Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, CytoMed Therapeutics is not overvalued.
Is CytoMed Therapeutics Stock a Buy?
- CytoMed Therapeutics share price is 2.62 while GDTC 8-day exponential moving average is 2.47, which is a Buy signal.
- The stock price of GDTC is 2.62 while CytoMed Therapeutics 20-day EMA is 2.33, which makes it a Buy.
- CytoMed Therapeutics 50-day exponential moving average is 2.07 while GDTC share price is 2.62, making it a Buy technically.
- GDTC stock price is 2.62 and CytoMed Therapeutics 200-day simple moving average is 2.22, creating a Buy signal.
Fundamental Analysis of CytoMed Therapeutics
Is CytoMed Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.02 per share.
Technical Analysis of CytoMed Therapeutics
Should I short CytoMed Therapeutics stock?
- GDTC Moving Average Covergence Divergence (MACD) indicator is 0.18, suggesting CytoMed Therapeutics is a Buy
- CytoMed Therapeutics Relative Strength Index (RSI) is 60.98, which suggest CytoMed Therapeutics is overbought
- The Bollinger Bands (25) for CytoMed Therapeutics is (1.91 - 2.59), which suggest CytoMed Therapeutics is a Buy
- The Bollinger Bands (100) for CytoMed Therapeutics is (1.55 - 2.23), which suggest CytoMed Therapeutics is a Buy
* CytoMed Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.